Lilly gets FDA nod on new osteoporosis drug use

[Joe]

Eli Lilly & Co said Friday that it had won approval to marketits blockbuster osteoporosis drug to post-menopausal women who areat high risk for invasive breast cancer.

More... (http://www.healthcentral.com/breast-cancer/news-160219-66.html)